Solasia Pharma K.K. (FRA:9SO)

Solasia Pharma K.K. Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,832	886	728	803	714	2,964
Cash & Short-Term Investments	1,832	886	728	803	714	2,964
Cash Growth	75.65%	21.70%	-9.34%	12.46%	-75.91%	-27.99%
Receivables	75	232	67	572	126	173
Inventory	138	128	122	14	-	4
Prepaid Expenses	-	17	57	43	48	64
Other Current Assets	31	3	2	3	6	64
Total Current Assets	2,076	1,266	976	1,435	894	3,269
Property, Plant & Equipment	122	47	81	63	120	102
Long-Term Investments	1	47	52	60	49	46
Other Intangible Assets	-	-	1,117	1,570	2,079	2,356
Other Long-Term Assets	141	2	3	6	2	2
Total Assets	2,340	1,362	2,229	3,134	3,144	5,775
Accounts Payable	378	121	213	332	386	987
Accrued Expenses	-	37	34	26	36	36
Current Portion of Long-Term Debt	-	-	-	-	-	1,000
Current Portion of Leases	31	25	33	37	47	39
Other Current Liabilities	45	10	13	12	20	17
Total Current Liabilities	454	193	293	407	489	2,079
Long-Term Leases	73	-	27	-	37	21
Long-Term Deferred Tax Liabilities	5	-	22	53	18	11
Other Long-Term Liabilities	12	13	12	12	13	12
Total Liabilities	544	206	354	472	557	2,123
Common Stock	788	2,211	1,596	1,436	2,110	1,402
Additional Paid-In Capital	1,408	2,255	1,657	1,500	5,738	5,043
Retained Earnings	-370	-3,277	-1,336	-223	-5,204	-2,726
Treasury Stock	-65	-65	-69	-70	-70	-70
Comprehensive Income & Other	35	32	27	19	13	3
Shareholders' Equity	1,796	1,156	1,875	2,662	2,587	3,652
Total Liabilities & Equity	2,340	1,362	2,229	3,134	3,144	5,775
Total Debt	104	25	60	37	84	1,060
Net Cash (Debt)	1,728	861	668	766	630	1,904
Net Cash Growth	71.60%	28.89%	-12.79%	21.59%	-66.91%	-52.96%
Net Cash Per Share	7.61	4.33	3.97	5.04	4.84	16.22
Filing Date Shares Outstanding	259.8	218.05	173.94	167.97	133.54	128.56
Total Common Shares Outstanding	259.8	218.05	173.94	167.97	133.51	122.64
Working Capital	1,622	1,073	683	1,028	405	1,190
Book Value Per Share	6.91	5.30	10.78	15.85	19.38	29.78
Tangible Book Value	1,796	1,156	758	1,092	508	1,296
Tangible Book Value Per Share	6.91	5.30	4.36	6.50	3.81	10.57

Source: S&P Global Market Intelligence. Standard template. Financial Sources.